| Reference |
|
5225
Fan D, Liaw A, Denkins YM, Collins JH, Van Arsdall M, Chang JL, Chakrabarty S, Nguyen D, Kruzel E, Fidler IJ.
Type-1 transforming growth factor-beta differentially modulates tumoricidal activity of murine peritoneal macrophages against metastatic variants of the B16 murine melanoma.
J Exp Ther Oncol
2002
2(5):286-97
PubMed ID: 12416032
|
|
5224
Dong Z, Yoneda J, Kumar R, Fidler IJ.
Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor.
J Exp Med
1998
188(4):755-63
PubMed ID: 9705957
|
|
5223
Esumi N, Fan D, Fidler IJ.
Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor.
Cancer Res
1991
51(17):4549-56
PubMed ID: 1873799
|
|
5221
Hart IR, Talmadge JE, Fidler IJ.
Comparative studies on the quantitative analysis of experimental metastatic capacity.
Cancer Res
1983
43(1):400-2
PubMed ID: 6291761
|
|
5220
Poste G, Doll J, Fidler IJ.
Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells.
Proc Natl Acad Sci U S A
1981
78(10):6226-30
PubMed ID: 6947225
|
|
5217
Raz A, Bucana C, McLellan W, Fidler IJ.
Distribution of membrane anionic sites on B16 melanoma variants with differing lung colonising potential.
Nature
1980
284(5754):363-4
PubMed ID: 7360272
|
|
5218
Hart IR, Raz A, Fidler IJ.
Effect of cytoskeleton-disrupting agents on the metastatic behavior of melanoma cells.
J Natl Cancer Inst
1980
64(4):891-900
PubMed ID: 6929000
|
|
5219
Poste G, Doll J, Hart IR, Fidler IJ.
In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties.
Cancer Res
1980
40(5):1636-44
PubMed ID: 7370995
|
|
5216
Fidler IJ, Nicolson GL.
Tumor cell and host properties affecting the implantation and survival of blood-borne metastatic variants of B16 melanoma.
Isr J Med Sci
1978
14(1):38-50
PubMed ID: 632082
|
|
5215
Fidler IJ, Bucana C.
Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.
Cancer Res
1977
37(11):3945-56
PubMed ID: 908034
|
|
5213
Fidler IJ, Gersten DM, Budmen MB.
Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity.
Cancer Res
1976
36(9 pt.1):3160-5
PubMed ID: 975082
|
|
5214
Fidler IJ, Nicolson GL.
Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines.
J Natl Cancer Inst
1976
57(5):1199-202
PubMed ID: 1003551
|
|
5212
Fidler IJ.
Biological behavior of malignant melanoma cells correlated to their survival in vivo.
Cancer Res
1975
35(1):218-24
PubMed ID: 1109790
|
| User's Publication |
|
11949
Kozaka S, Tahara Y, Wakabayashi R, Nakata T, Ueda T, Kamiya N, Goto M.
Transcutaneous Cancer Vaccine Using a Reverse Micellar Antigen Carrier.
Mol. Pharm.
2020
PubMed ID: 31833775
|
|
12095
Baba K, Nomura M, Ohashi S, Hiratsuka T, Nakai Y, Saito T, Kondo Y, Fukuyama K, Kikuchi O, Yamada A, Matsubara J, Hirohashi K, Mitani Y, Mizumoto A, Muto M.
Experimental model for the irradiation-mediated abscopal effect and factors influencing this effect.
Am J Cancer Res
2020
PubMed ID: 32195019
|
|
12122
Makbal R, Villareal MO, Gadhi C, Hafidi A, Isoda H.
Argania Spinosa Fruit Shell Extract-Induced Melanogenesis via cAMP Signaling Pathway Activation.
Int J Mol Sci
2020
PubMed ID: 32268492
|
|
12174
Myra O. Villareal, Thanyanan Chaochaiphat, Meriem Bejaoui, Kozo Sato, Hiroko Isoda
Tara Tannin Regulates Pigmentation by Modulating Melanogenesis Enzymes and Melanosome Transport Proteins Expression
Planta Medica
2020
|
|
12201
Irmanida Batubara, Rika Indri Astuti, Muhammad Eka Prastya, Auliya Ilmiawati, Miwa Maeda, Mayu Suzuki, Akie Hamamoto, Hiroshi Takemori
The Antiaging Effect of Active Fractions and Ent-11α-Hydroxy-15-Oxo-Kaur-16-En-19-Oic Acid Isolated from Adenostemma lavenia (L.) O. Kuntze at the Cellular Level
Antioxidants (Basel)
2020
9(8):719
PubMed ID: 32784463
|
|
11294
Zhou S, Sakamoto K.
Pyruvic acid/ethyl pyruvate inhibits melanogenesis in B16F10 melanoma cells through PI3K/AKT, GSK3β, and ROS-ERK signaling pathways.
Genes Cells
2019
PubMed ID: 30417494
|
|
11549
Chowdhury MR, Moshikur RM, Wakabayashi R, Tahara Y, Kamiya N, Moniruzzaman M, Goto M.
In vivo biocompatibility, pharmacokinetics, antitumor efficacy, and hypersensitivity evaluation of ionic liquid-mediated paclitaxel formulations.
Int J Pharm
2019
PubMed ID: 31077761
|
|
11612
Sugiyama Y, Shudo T, Hosokawa S, Watanabe A, Nakano M, Kakizuka A.
Emodin, as a mitochondrial uncoupler, induces strong decreases in adenosine triphosphate (ATP) levels and proliferation of B16F10 cells, owing to their poor glycolytic reserve.
Genes Cells
2019
PubMed ID: 31234244
|
|
11645
Yamada H, Hakozaki M, Uemura A, Yamashita T.
Effect of fatty acids on melanogenesis and tumor cell growth in melanoma cells.
J. Lipid Res.
2019
PubMed ID: 31345992
|
|
11698
Kazuomi Sato, Yuji Yamaguchi, Setsuko Sakaki, Hiroyuki Takenaka
Pleurochrysis carterae Hot-Water Extract Inhibits Melanogenesis in Murine Melanoma Cells
Cosmetics
2019
|
|
11795
Tan YH, Shudo T, Yoshida T, Sugiyama Y, Si JY, Tsukano C, Takemoto Y, Kakizuka A.
Ellagic acid, extracted from Sanguisorba officinalis, induces G1 arrest by modulating PTEN activity in B16F10 melanoma cells.
Genes Cells
2019
PubMed ID: 31495058
|
|
11828
Morikura T, Miyata S.
Effect of Mechanical Compression on Invasion Process of Malignant Melanoma Using In Vitro Three-Dimensional Cell Culture Device.
Micromachines (Basel)
2019
PubMed ID: 31575066
|
|
4074
Plasma-Induced Suppression of Recurrent and Reinoculated Melanoma Tumors in Mice
IEEE Transactions on Radiation and Plasma Medical Sciences
2018
2:353 - 359
|
|
4151
Manome Y, Suzuki D, Mochizuki A, Saito E, Sasa K, Yoshimura K, Inoue T, Takami M, Inagaki K, Funatsu T, Kamijo R.
The inhibition of malignant melanoma cell invasion of bone by the TLR7 agonist R848 is dependent upon pro-inflammatory cytokines produced by bone marrow macrophages.
Oncotarget
2018
PubMed ID: 30042824
|
|
4158
Shimada K, Ushijima K, Suzuki C, Horiguchi M, Ando H, Akita T, Shimamura M, Fujii J, Yamashita C, Fujimura A.
Pulmonary administration of curcumin inhibits B16F10 melanoma lung metastasis and invasion in mice.
Cancer Chemother. Pharmacol.
2018
PubMed ID: 29869202
|
|
4470
Villareal MO, Sato Y, Matsuyama K, Isoda H.
Daphnane diterpenes inhibit the metastatic potential of B16F10 murine melanoma cells in vitro and in vivo.
BMC Cancer
2018
18(1):856
PubMed ID: 30157785
|
|
10617
Villareal MO, Kume S, Neffati M, Isoda H.
Upregulation of Mitf by Phenolic Compounds-Rich Cymbopogon schoenanthus Treatment Promotes Melanogenesis in B16 Melanoma Cells and Human Epidermal Melanocytes.
Biomed Res Int
2017
2017:8303671
PubMed ID: 29359158
|
|
4527
Yumi Abe, Wakako Takabe, Masayuki Yagi, Akemi Uwaya, Fumiyuki Isami, Yoshikazu Yonei
Inhibition of AGE-induced Melanogenesis in B16 Melanoma Cells by Iridoid-containing Plants
Glycative Stress Research
2017
4 (1): 067-070
|
|
7375
Kim HJ, Kim IS, Dong Y, Lee IS, Kim JS, Kim JS, Woo JT, Cha BY.
Melanogenesis-inducing effect of cirsimaritin through increases in microphthalmia-associated transcription factor and tyrosinase expression.
Int J Mol Sci
2015
16:8772-88
PubMed ID: 25903150
|
|
5420
Katoh D, Nishizuka M1, Osada S1, Imagawa M1.
Fad104, a positive regulator of adipocyte differentiation, suppresses invasion and metastasis of melanoma cells by inhibition of STAT3 activity.
PLoS One
2015
10(2):e0117197
PubMed ID: 25671570
|
Back
Top
CELL BANK Website
